EP


Journal

Acta physiologica (Oxford, England)
ISSN: 1748-1716
Titre abrégé: Acta Physiol (Oxf)
Pays: England
ID NLM: 101262545

Informations de publication

Date de publication:
03 2022
Historique:
revised: 09 12 2021
received: 02 07 2021
accepted: 01 01 2022
pubmed: 7 1 2022
medline: 30 4 2022
entrez: 6 1 2022
Statut: ppublish

Résumé

Renal fibrosis is a major driver of chronic kidney disease, yet current treatment strategies are ineffective in attenuating fibrogenesis. The cyclooxygenase/prostaglandin system plays a key role in renal injury and holds great promise as a therapeutic target. Here, we used a translational approach to evaluate the role of the PGE The anti-fibrotic efficacy of a selective EP EP This study highlights the EP

Identifiants

pubmed: 34989478
doi: 10.1111/apha.13780
pmc: PMC9286353
doi:

Substances chimiques

Transforming Growth Factor beta 0
Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide 19395-87-0
Collagen 9007-34-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13780

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.

Références

Kidney Int. 1999 Aug;56(2):589-600
pubmed: 10432398
J Am Assoc Lab Anim Sci. 2011 Sep;50(5):600-13
pubmed: 22330705
J Am Soc Nephrol. 1999 Sep;10(9):1851-60
pubmed: 10477136
Lab Invest. 2020 Mar;100(3):414-425
pubmed: 31527829
Transl Res. 2016 Apr;170:8-16.e1
pubmed: 26687735
Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1430-9
pubmed: 22397925
Int J Mol Med. 2015 Jan;35(1):285-93
pubmed: 25352206
Kidney Int. 2012 Jul;82(2):158-71
pubmed: 22513820
J Am Soc Nephrol. 1996 Jan;7(1):8-17
pubmed: 8808104
Am J Physiol Renal Physiol. 2015 Dec 15;309(12):F1035-48
pubmed: 26671967
J Pharm Pharm Sci. 2018;21(1):326-339
pubmed: 30075829
Kidney Int Suppl. 1998 Sep;67:S88-94
pubmed: 9736261
Cell Rep. 2013 Aug 15;4(3):530-41
pubmed: 23911286
Nat Med. 2013 Aug;19(8):1047-53
pubmed: 23817022
Histol Histopathol. 2010 Aug;25(8):995-1007
pubmed: 20552550
Calcif Tissue Int. 1998 Apr;62(4):327-31
pubmed: 9504958
Expert Opin Drug Discov. 2020 Jan;15(1):101-115
pubmed: 31736379
Lab Invest. 2018 Mar;98(3):360-370
pubmed: 29251736
Nature. 2021 Jan;589(7841):281-286
pubmed: 33176333
Pharmaceutics. 2020 May 18;12(5):
pubmed: 32443499
Kidney Int. 2006 Sep;70(6):1099-106
pubmed: 16871242
Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F777-F786
pubmed: 27413198
Am J Physiol Regul Integr Comp Physiol. 2010 Apr;298(4):R1017-25
pubmed: 20147610
Nat Med. 2015 Jan;21(1):37-46
pubmed: 25419705
Am J Physiol Renal Physiol. 2011 Dec;301(6):F1303-13
pubmed: 21880835
Anal Biochem. 2013 Feb 15;433(2):105-11
pubmed: 23085117
J Rheumatol Suppl. 1997 Jul;49:15-9
pubmed: 9249646
Mol Pharmacol. 2010 Jun;77(6):1025-36
pubmed: 20335389
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Kidney Res Clin Pract. 2022 Jan;41(1):4-13
pubmed: 35108767
Lab Invest. 2015 Sep;95(9):1044-55
pubmed: 26121313
Am J Physiol Renal Physiol. 2005 Aug;289(2):F322-33
pubmed: 15840770
Can J Physiol Pharmacol. 2006 Aug-Sep;84(8-9):877-85
pubmed: 17111032
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
Am J Physiol Renal Physiol. 2014 Jan;306(2):F259-70
pubmed: 24226522
Pharm Res. 2019 Dec 23;37(1):12
pubmed: 31873819
Acta Physiol (Oxf). 2019 Sep;227(1):e13291
pubmed: 31054202
Am J Physiol Regul Integr Comp Physiol. 2010 Sep;299(3):R823-31
pubmed: 20610829
Cell Physiol Biochem. 2015;36(5):1911-27
pubmed: 26202352
Curr Opin Pharmacol. 2019 Dec;49:82-89
pubmed: 31671319
J Biol Chem. 1993 Sep 25;268(27):20175-8
pubmed: 7690750
Acta Physiol (Oxf). 2022 Mar;234(3):e13780
pubmed: 34989478
Hypertension. 2003 Dec;42(6):1183-90
pubmed: 14670979
Nat Rev Nephrol. 2020 May;16(5):269-288
pubmed: 32060481
Theranostics. 2015 Jan 01;5(2):110-23
pubmed: 25553102
Trends Mol Med. 2016 Jan;22(1):4-6
pubmed: 26700490
Eur J Biochem. 1995 Aug 1;231(3):809-14
pubmed: 7649181
Am J Pathol. 2013 Dec;183(6):1789-1802
pubmed: 24113456
J Am Soc Nephrol. 1999 Oct;10(10):2084-93
pubmed: 10505684
Acta Physiol (Oxf). 2022 Feb;234(2):e13760
pubmed: 34978750

Auteurs

Jean-Claude Kresse (JC)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Henricus A M Mutsaers (HAM)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Michael Schou Jensen (MS)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Stine Julie Tingskov (SJ)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Mia Gebauer Madsen (MG)

Department of Urology, Aarhus University Hospital, Aarhus, Denmark.

Lene N Nejsum (LN)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Helle Praetorius (H)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Rikke Nørregaard (R)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH